Fusion Pharmaceuticals Inc. (37) | License Agreements (2)
- License Agreement, dated as of February 22, 2017, by and between the Centre for Probe Development and Commercialization Inc. and the Registrant (Filed With SEC on June 5, 2020)
- License Agreement, dated as of December 19, 2016, by and between ImmunoGen, Inc. and the Registrant, as amended (Filed With SEC on June 5, 2020)
